Literature DB >> 12070631

Enhanced chemosensitivity after intermittent hypoxic exposure does not affect exercise ventilation at sea level.

Keisho Katayama1, Yasutake Sato, Norihiro Shima, Jin Chang Qiu, Koji Ishida, Shigeo Mori, Miharu Miyamura.   

Abstract

The purpose of the present study was to test the hypothesis that the ventilatory response to exercise at sea level may increase after intermittent hypoxic exposure for 1 week, accompanied by an increase in hypoxic or hypercapnic ventilatory chemosensitivity. One group of eight subjects (hypoxic group) were decompressed in a chamber to 432 torr (where 1 torr=1.0 mmHg, simulating an altitude of 4,500 m) over a period of 30 min and maintained at that pressure for 1 h daily for 7 days. Oxygen uptake and pulmonary ventilation (V(E)) were determined at 40%, 70%, and 100% of maximal oxygen uptake at sea level before (Pre) and after (Post) 1 week of daily exposures to hypoxia. The hypoxic ventilatory response (HVR) was determined using the isocapnic progressive hypoxic method as an index of ventilatory chemosensitivity to hypoxia, and the hypercapnic ventilatory response (HCVRSB) was measured by means of the single-breath carbon dioxide method as an index of peripheral ventilatory chemosensitivity to hypercapnia. The same parameters were measured in another group of six subjects (control group). In the hypoxic group, resting HVR increased significantly ( P<0.05) after intermittent hypoxia and HCVRSB increased at Post, but the change was not statistically significant ( P=0.07). In contrast, no changes in HVR and HCVRSB were found in the control group. There were no changes in either V(E) or the ventilatory equivalent for oxygen during maximal and submaximal exercise at sea level throughout the experimental period in either group. These results suggest that the changes in resting hypoxic and peripheral hypercapnic chemosensitivities following short-term intermittent hypoxia have little effect on exercise ventilation at sea level.

Entities:  

Mesh:

Year:  2002        PMID: 12070631     DOI: 10.1007/s00421-002-0594-4

Source DB:  PubMed          Journal:  Eur J Appl Physiol        ISSN: 1439-6319            Impact factor:   3.078


  7 in total

1.  Hypoxic ventilatory response is correlated with increased submaximal exercise ventilation after live high, train low.

Authors:  Nathan E Townsend; Christopher J Gore; Allan G Hahn; Robert J Aughey; Sally A Clark; Tahnee A Kinsman; Michael J McKenna; John A Hawley; Chin-Moi Chow
Journal:  Eur J Appl Physiol       Date:  2004-12-18       Impact factor: 3.078

2.  Effect of two durations of short-term intermittent hypoxia on ventilatory chemosensitivity in humans.

Authors:  Keisho Katayama; Koji Ishida; Ken-Ichi Iwasaki; Miharu Miyamura
Journal:  Eur J Appl Physiol       Date:  2009-01-06       Impact factor: 3.078

3.  Effects of two protocols of intermittent hypoxia on human ventilatory, cardiovascular and cerebral responses to hypoxia.

Authors:  Glen E Foster; Donald C McKenzie; William K Milsom; A William Sheel
Journal:  J Physiol       Date:  2005-06-23       Impact factor: 5.182

4.  Effects of intermittent hypoxia on the cerebrovascular responses to submaximal exercise in humans.

Authors:  Jordan S Querido; James L Rupert; Donald C McKenzie; A William Sheel
Journal:  Eur J Appl Physiol       Date:  2008-11-08       Impact factor: 3.078

5.  Kikuchi-fujimoto disease: diagnostic dilemma and the role of immunohistochemistry.

Authors:  Mehboob Hassan; Afzal Anees; Sufian Zaheer
Journal:  J Clin Med Res       Date:  2009-10-16

Review 6.  Intermittent hypoxia in childhood: the harmful consequences versus potential benefits of therapeutic uses.

Authors:  Tatiana V Serebrovskaya; Lei Xi
Journal:  Front Pediatr       Date:  2015-05-19       Impact factor: 3.418

7.  Respiratory control during air-breathing exercise in humans following an 8 h exposure to hypoxia.

Authors:  Mari Herigstad; Marzieh Fatemian; Peter A Robbins
Journal:  Respir Physiol Neurobiol       Date:  2008-06-14       Impact factor: 1.931

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.